Quickstart Highlights

Mechano Growth Factor (MGF) is a splice variant of IGF‑1 (IGF‑1Ec in humans) produced in response to mechanical stress and tissue damage^[1][2]. Research indicates MGF plays a role in muscle repair, satellite cell activation, and bone regeneration^[3][4]. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

• Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
• Typical daily range: 100–300 mcg once daily (gradual titration).
• Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U‑100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within ~30 days.

Protocol Overview

Concise summary of the once‑daily regimen.

• Goal: Support tissue repair and regenerative processes through localized growth factor signaling^[3][4].
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 100–300 mcg daily with gradual titration.
• Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

• Start: 100 mcg daily; increase by ~50 mcg weekly as tolerated.
• Target: 250–300 mcg daily by Weeks 4–8.
• Frequency: Once per day (subcutaneous).
• Cycle Length: 8–12 weeks; optional extension to 16 weeks.
• Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality^[5][6].

• Lyophilized: Store at −20 °C (−4 °F) or colder for long‑term; refrigerate at 4 °C (39.2 °F) for short‑term.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within approximately 30 days; avoid freeze–thaw cycles.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation^[7].
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.
• MGF has a short half‑life; PEGylated forms (PEG‑MGF) offer extended duration but follow different protocols^[2].

How This Works

MGF is generated through alternative splicing of the IGF‑1 gene in response to mechanical loading or tissue injury^[1][2]. The resulting peptide contains a unique C‑terminal E domain that distinguishes it from systemic IGF‑1. Preclinical research demonstrates MGF activates satellite cells (muscle stem cells), promotes osteoblast proliferation, and supports neurogenesis^[3][4][8]. These effects appear to be localized and transient, suggesting MGF acts primarily as a tissue‑specific repair signal rather than a systemic growth factor.

Potential Benefits & Side Effects

Observations from preclinical literature (no formal human clinical trials have been completed).

• Promotes satellite cell activation and myoblast proliferation in muscle tissue^[1][9].
• Supports bone defect healing and osteoblast activity in animal models^[3].
• May promote neurogenesis and neuroprotection in aging brain tissue^[8].
• Generally well tolerated in preclinical settings; occasional mild injection‑site reactions may occur with subcutaneous administration.
• Long‑term safety data in humans is limited; preclinical models suggest localized rather than systemic effects.

Lifestyle Factors

Complementary strategies for best outcomes.

• Pair with resistance training to provide the mechanical stimulus that naturally upregulates MGF expression^[1].
• Ensure adequate protein intake (1.6–2.2 g/kg) to support tissue repair processes.
• Prioritize sleep and recovery; growth factor activity is enhanced during rest periods.
• Manage inflammation through balanced nutrition to optimize the repair environment.

Injection Technique

General subcutaneous guidance from clinical best‑practice resources^[10].

• Clean the vial stopper and skin with alcohol; allow to dry.
• Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue^[7][11].
• Do not aspirate for subcutaneous injections; inject slowly and steadily^[7].
• Rotate sites systematically (abdomen, thighs, upper arms) by at least 1–1.5 inches from prior sites to avoid irritation^[11].
• Use 23–25 gauge, 5/8‑inch needles for subcutaneous administration^[7].

Recommended Source

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Amino Labs

References